SciSparc Says European Patent Office Granted Company's Patent Application Titled "Compositions And Methods Of Potentiating Antimicrobials"
Portfolio Pulse from Benzinga Newsdesk
SciSparc has been granted a patent by the European Patent Office for 'Compositions And Methods Of Potentiating Antimicrobials,' adding to a similar patent previously granted by the United States Patent and Trademark Office. This strengthens the company's intellectual property portfolio and competitive position in the global pharmaceutical market.
May 31, 2024 | 11:21 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
SciSparc has been granted a European patent for 'Compositions And Methods Of Potentiating Antimicrobials,' which strengthens its intellectual property portfolio and competitive position in the global pharmaceutical market.
The European patent grant adds to SciSparc's existing US patent, bolstering its IP portfolio and competitive position. This is likely to positively impact the company's stock price in the short term as it enhances its market position and potential for future revenue.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100